Clinical Trial

Measuring Oncological Value of Exercise and Statin

Study acronym: MOVES
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of the study is to find out whether supervised physical exercise during cancer drug treatment improves the effectiveness of the treatment in metastasized breast, kidney, ovarian and prostate cancer compared to unsupervised exercise. In addition, the investigators are investigating whether the use of atorvastatin combined with guided group exercise training would further improve the response to cancer treatment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-04-03; most recent amendment 2025-06-23.
Status change: Not Yet Recruiting → Recruiting 2023-05-23
Trial Details
NCT Number NCT05796973
Lead Sponsor Tampere University Hospital
Collaborators: Tampere University, Aalto University, University of Helsinki, University of Turku
Conditions Prostate Cancer, Breast Cancer, Kidney Cancer, Ovarian Cancer, Metastatic Breast Cancer, Metastatic Kidney Cancer, Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer +4 more
Enrollment 240 participants
Start Date 2023-03-31
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-27